Genentech Inc. didn’t need to wait until Thanksgiving for the U.S. FDA to make up its mind. More than a month ahead of its PDUFA date, the agency approved the firm’s first-line breast cancer treatment ...

*Based on data released by the Federal Election Commission on October 17, 2024 except for independent expenditure and communication cost, contributions to federal candidates, and contributions from ...

As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential ...

ADMINISTRATIVE: The operational costs of running a campaign or PAC, including travel expenses, office rent and supplies, utilities, equipment, food, meetings, and administrative services such as ...

Aviv Regev, executive vice president and head of Genentech Research & Early Development (gRED) NVIDIA’s push into the life sciences sector has been rewarded by a wide-ranging deal with Roche’s ...

Genentech, a member of the Roche (RHHBY), announced that it will present more than 40 abstracts across nine blood disorders at the 66th ...

Roche’s Genentech unit signed a trio of deals this week to add new drug discovery platforms to its repertoire. The three drug discovery deals are with Convelo Therapeutics in neurological ...

Spending $100,000 on a treatment program that is either entirely useless, or which will buy a brain-cancer patient a few extra weeks of life, would have been an irresponsible use of government ...

Genentech Inc. will be cutting 436 jobs at its South San Francisco headquarters. Sanofi, which is headquartered in Paris, will also be cutting 100 jobs at its South SF office, according to notices ...

Roche Group unit Genentech said that the Food and Drug Administration approved Itovebi for treating certain breast cancer. The approval is for Itovebi in combination with palbociclib and ...

RICHMOND, Calif., November 12, 2024 -- ( BUSINESS WIRE )--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today reported business highlights and third quarter 2024 financial ...

Lineage Cell Therapeutics Inc (LCTX) extends its cash runway and progresses in key partnerships, despite facing regulatory ...